Evidence map›Paper›PMID 32714188›Full record

ArticleFrontiers in pharmacology2020

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain.

Giuseppe Di Giovanni, Rahul Bharatiya, Emilie Puginier, Marta Ramos, Salomé De Deurwaerdère, Abdeslam Chagraoui, Philippe De Deurwaerdère

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Editorial: Contemporary Perspective on 5-HTFrontiers in pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Giuseppe Di GiovanniLaboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Rahul BharatiyaCentre National de la Recherche Scientifique, UMR CNRS 5287, Bordeaux, France.
Emilie PuginierCentre National de la Recherche Scientifique, UMR CNRS 5287, Bordeaux, France.
Marta RamosLaboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Salomé De DeurwaerdèreCentre National de la Recherche Scientifique, UMR CNRS 5287, Bordeaux, France.
Abdeslam ChagraouiNormandie Univ, UNIROUEN, INSERM, U1239, CHU Rouen, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Rouen, France.
Philippe De DeurwaerdèreCentre National de la Recherche Scientifique, UMR CNRS 5287, Bordeaux, France.
Centre National de la Recherche Scientifique · FRUniversity of Malta · MTInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lorcaserin is a preferential serotonin2C receptor (5-HT

Indexed as

amygdalabraincorrelationcortexelectrochemical detectionhigh-pressure liquid chromatographymonoaminesnucleus accumbens

Identifiers

PMID32714188
PMCPMC7344148
OpenAlexW3035986998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.